Figure 2From: Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules Reasons for non-adherence in patients switched from SGCs BID to tablets BID. Back to article page